A nurse is providing teaching at a community health fair about electrical fire prevention. Which of the following information should the nurse include in the teaching?

Choice A reason: Decreasing fluid intake to firm stools is incorrect, as adequate hydration (2-3 L/day) is essential to prevent constipation, especially with opioids like oxycodone, which slow intestinal motility. Low fluid intake hardens stools, exacerbating constipation risk by reducing water content in the colon, indicating a misunderstanding of prevention strategies.
Choice B reason: Increasing dietary fiber intake (25-35 g/day) adds bulk to stools, stimulating peristalsis and counteracting opioid-induced slowed motility. Soluble and insoluble fiber, found in fruits, vegetables, and whole grains, promotes regular bowel movements. This statement reflects correct understanding of dietary measures to prevent constipation during opioid therapy.
Choice C reason: Taking a laxative only when constipated is reactive, not preventive. Opioids like oxycodone commonly cause constipation by reducing peristalsis via mu-opioid receptors in the gut. Prophylactic use of stool softeners or laxatives is recommended to maintain regular bowel movements, making this statement incorrect as it lacks a preventive approach.
Choice D reason: Exercising less to conserve energy worsens constipation, as physical activity stimulates intestinal motility, countering opioid-induced slowing. Regular movement, like walking, promotes bowel function by enhancing peristalsis and blood flow to the gut. This statement indicates a misunderstanding, as reduced activity increases constipation risk.

Choice A reason: Fibromyalgia, a chronic pain condition, is not a contraindication for oral contraceptives. Estrogen and progesterone do not exacerbate fibromyalgia’s musculoskeletal or neurological symptoms, as they primarily affect hormonal pathways, making contraceptives safe for use in clients with this condition.
Choice B reason: Hypertension is a contraindication for oral contraceptives, as estrogen increases renin-angiotensin activity, elevating blood pressure. This risks cardiovascular events like stroke or myocardial infarction, especially in clients with existing hypertension, necessitating alternative contraception to avoid vascular complications.
Choice C reason: Iron-deficiency anemia is not a contraindication, as oral contraceptives may reduce menstrual bleeding, improving anemia by decreasing iron loss. Their hormonal effects do not impact erythropoiesis, making them potentially beneficial for anemic clients, unlike hypertension, which poses risks.
Choice D reason: Human papillomavirus (HPV) is not a contraindication, as it affects cervical epithelium, not hormonal pathways. While some studies suggest a weak link to cervical cancer, HPV vaccination and screening mitigate risks, making oral contraceptives safe for clients with HPV.